Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial

Background: Several early phase studies have demonstrated that psilocybin-assisted therapy has rapid-acting and persisting antidepressant effects from just one or two doses. However, methodological limitations (e.g., placebo-control, blinding) limit interpretability of the existing literature. Metho...

Ausführliche Beschreibung